2021
DOI: 10.1002/ajmg.a.62565
|View full text |Cite
|
Sign up to set email alerts
|

Quantitative dissection of multilocus pathogenic variation in an Egyptian infant with severe neurodevelopmental disorder resulting from multiple molecular diagnoses

Abstract: Genomic sequencing and clinical genomics have demonstrated that substantial subsets of atypical and/or severe disease presentations result from multilocus pathogenic variation (MPV) causing blended phenotypes. In an infant with a severe neurodevelopmental disorder, four distinct molecular diagnoses were found by exome sequencing (ES). The blended phenotype that includes brain malformation, dysmorphism, and hypotonia was dissected using the Human Phenotype Ontology (HPO). ES revealed variants in CAPN3 (c.259C >… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
3
1
1

Citation Types

0
17
0

Year Published

2021
2021
2024
2024

Publication Types

Select...
6
1
1

Relationship

3
5

Authors

Journals

citations
Cited by 16 publications
(17 citation statements)
references
References 56 publications
(109 reference statements)
0
17
0
Order By: Relevance
“…We then tested the extent to which mutational burden caused by rare homozygous deleterious variants in long-sized ROH regions explains clinical phenotypic features of the individuals in the TK cohort. To achieve this, we performed an unbiased genotype-phenotype correlation analysis based on the HPO terms (Herman et al, 2022; Zhang et al, 2022). In this analysis, we first linked the disease genes present with rare coding homozygous and deleterious variation in an individual genome to their related HPO terms for the trait, as defined in the OMIM (https://www.omim.org) clinical synopsis, according to HPO annotation resource databases.…”
Section: Resultsmentioning
confidence: 99%
“…We then tested the extent to which mutational burden caused by rare homozygous deleterious variants in long-sized ROH regions explains clinical phenotypic features of the individuals in the TK cohort. To achieve this, we performed an unbiased genotype-phenotype correlation analysis based on the HPO terms (Herman et al, 2022; Zhang et al, 2022). In this analysis, we first linked the disease genes present with rare coding homozygous and deleterious variation in an individual genome to their related HPO terms for the trait, as defined in the OMIM (https://www.omim.org) clinical synopsis, according to HPO annotation resource databases.…”
Section: Resultsmentioning
confidence: 99%
“…Further study of the phenotypic effect of SMARCC2 and SPEN duplication in more patients, rather than deletion, is necessary to understand dosage sensitivity (i.e., triplosensitivity) at these loci; however, these data in aggregate support the contention that the phenotype of the proband is a blended overlapping phenotype driven by multilocus pathogenic variation (MPV) [ 21 , 61 ], i.e., duplication of the NSD1 and SMARCC2 loci, and their associated traits. Our understanding of emerging concepts, such as which genes or loci are dosage-sensitive, whether haploinsufficiency and triplosensitivity traits will be observed for a given dosage-sensitive gene, and the correlation between dosage-sensitive genes and mirror traits is continuing to evolve with human genetics and genomics studies.…”
Section: Discussionmentioning
confidence: 99%
“…To perform quantitative phenotype analysis, we used a similar method to that previously published [ 21 – 23 ] with modification; a detailed description follows. The patient’s clinical description was translated to HPO terms using Doc2Hpo [ 24 ] and manually verified.…”
Section: Methodsmentioning
confidence: 99%
“…Concerning overall phenotypic heterogeneity, human phenotype ontology (HPO)-based quantitative phenotypic analysis will be adapted in the future to quantify the limb anomaly trait and investigate the allele-specific differences (or to uncover novel allelic series) in similar CLM spectrums as well as to dissect MPV in AR or AD blended traits. 74 , 97 Autozygosity mapping and AOH/ROH analyses from unphased exome data in consanguineous families could assist with additional novel disease gene/locus discovery in consanguineous families. 98 These strategies extend the effort to test the hypothesis proposed by Coban-Akdemir et al.…”
Section: Discussionmentioning
confidence: 99%
“…Future explorations will compare the allelic-specific gene dosage (AsGD) model proposed in this study with the established compound inheritance gene dosage model (CIGD) model to test this hypothesis and provide evidence as to whether such gene dosage expression models significantly contribute to limb anomalies and other developmental malformations. 95 , 97 …”
Section: Discussionmentioning
confidence: 99%